Clinical Trials for Thoracic Cancers
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Clinical Research of Cancer".
Deadline for manuscript submissions: 30 December 2025 | Viewed by 37
Special Issue Editor
2. Department of Oncology and Hemato-Oncology, University of Milan, 20141 Milan, Italy
Interests: lung cancer; minimally invasive surgery; robotic surgery; mesothelioma; thymoma
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Thoracic cancers, including lung, thymic, and pleural malignancies, remain among the most lethal oncologic entities worldwide. In recent years, clinical research has witnessed a paradigm shift from traditional cytotoxic therapies to biomarker-driven treatments, immuno-oncology, and multimodal strategies, including advanced surgical and radiotherapy protocols. Innovations in trial design have accelerated the dynamic evolution of clinical trials, the increasing integration of artificial intelligence, and the growing emphasis on real-world evidence to complement randomized controlled trials.
This Special Issue aims to capture the breadth of ongoing progress in thoracic oncology clinical trials, focusing on innovative methodologies, translational applications, and patient-centered outcomes. We welcome original research, systematic reviews, and perspectives that address key topics such as precision medicine, novel endpoints, adaptive trial models, and the implementation of multidisciplinary treatment pathways. Contributions are especially encouraged in exploring neoadjuvant and adjuvant settings, minimally invasive interventions, and longitudinal analyses of patient-reported outcomes. By uniting diverse perspectives from thoracic surgeons, oncologists, radiologists, and data scientists, this issue aspires to foster deeper insights into how clinical research is shaping the future of thoracic cancer care.
Dr. Monica Casiraghi
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- lung cancer
- thoracic oncology
- thymoma
- mesothelioma
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
